Lenalidomide on alternative days is effective in myelodysplastic syndrome with 5q- deletion.
Defina
Marzia
M
Rondoni
Michela
M
Gozzetti
Alessandro
A
Aprile
Lara
L
Chitarrelli
Ida
I
Fabbri
Alberto
A
Lauria
Francesco
F
Bocchia
Monica
M
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide